Matthew Terry, PhD
About Matthew Terry, PhD
Matteo Trotta is the Executive Vice President and General Manager of U.S. Dermatology at Incyte, with over 15 years of experience in the pharmaceutical industry.
Matteo Trotta's Role at Incyte
Matteo Trotta joined Incyte in 2024 as Executive Vice President and General Manager of U.S. Dermatology. In his role, he oversees the dermatology segment within the United States, drawing on over 15 years of experience within the pharmaceutical industry. His leadership is expected to bring strategic direction and growth to the dermatology division at Incyte.
Matteo Trotta's Experience at Novartis
Before joining Incyte, Matteo Trotta served as the Head of Novartis U.S. Immunology. During his tenure, he led a 400-person organization focused on multiple specialties, including dermatology, rheumatology, auto-inflammatory rare diseases, and allergy. His leadership roles spanned U.S. marketing and sales, enterprise strategy, and global manufacturing and quality operations.
Matteo Trotta's Career at McKinsey & Company
Matteo Trotta worked as an Engagement Manager at McKinsey & Company, where he specialized in serving pharmaceutical and payer clients. This experience provided him with critical insights into the healthcare industry and solidified his consulting expertise in pharmaceutical strategies.
Matteo Trotta's Educational Background
Matteo Trotta holds an Engineering Degree from Politecnico di Torino. He furthered his education with a Master of Science in Engineering from the University of Illinois Chicago. Additionally, he earned a Master of Business Administration from Columbia Business School. These academic credentials have provided him with a strong foundation in both technical and managerial disciplines.
Matteo Trotta's Early Career Roles
At the outset of his career, Matteo Trotta held roles at GM-FIAT Worldwide Purchasing. This early experience in the automotive industry provided him with valuable operational and strategic insights, which he later applied in leadership positions within the pharmaceutical sector.